BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25847421)

  • 1. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
    Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.
    Kucab JE; Zwart EP; van Steeg H; Luijten M; Schmeiser HH; Phillips DH; Arlt VM
    DNA Repair (Amst); 2016 Mar; 39():21-33. PubMed ID: 26723900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of N-hydroxy-4-aminobiphenyl in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Hölzl-Armstrong L; Kucab JE; Zwart EP; Luijten M; Phillips DH; Arlt VM
    Environ Mol Mutagen; 2021 Apr; 62(4):252-264. PubMed ID: 33620775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Hölzl-Armstrong L; Kucab JE; Moody S; Zwart EP; Loutkotová L; Duffy V; Luijten M; Gamboa da Costa G; Stratton MR; Phillips DH; Arlt VM
    Arch Toxicol; 2020 Dec; 94(12):4173-4196. PubMed ID: 32886187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.
    John K; Pratt MM; Beland FA; Churchwell MI; McMullen G; Olivero OA; Pogribny IP; Poirier MC
    Carcinogenesis; 2012 Nov; 33(11):2236-41. PubMed ID: 22828138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability.
    Menzies GE; Reed SH; Brancale A; Lewis PD
    Nucleic Acids Res; 2015 Oct; 43(19):9133-46. PubMed ID: 26400171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of diesel exhaust carcinogens in primary and immortalized human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE; Phillips DH; Arlt VM
    Environ Mol Mutagen; 2012 Apr; 53(3):207-17. PubMed ID: 22351035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutlin-3a selects for cells harbouring TP53 mutations.
    Kucab JE; Hollstein M; Arlt VM; Phillips DH
    Int J Cancer; 2017 Feb; 140(4):877-887. PubMed ID: 27813088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene
    Hölzl-Armstrong L; Kucab JE; Korenjak M; Luijten M; Phillips DH; Zavadil J; Arlt VM
    Methods Protoc; 2019 Nov; 2(4):. PubMed ID: 31766274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.
    de Vries A; Dollé ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H
    Carcinogenesis; 1997 Dec; 18(12):2327-32. PubMed ID: 9450477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
    Hu W; Feng Z; Tang MS
    Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.
    Liu Z; Muehlbauer KR; Schmeiser HH; Hergenhahn M; Belharazem D; Hollstein MC
    Cancer Res; 2005 Apr; 65(7):2583-7. PubMed ID: 15805253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach.
    Tretyakova N; Matter B; Jones R; Shallop A
    Biochemistry; 2002 Jul; 41(30):9535-44. PubMed ID: 12135376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
    Denissenko MF; Pao A; Tang M; Pfeifer GP
    Science; 1996 Oct; 274(5286):430-2. PubMed ID: 8832894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
    Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
    Kucab JE; Phillips DH; Arlt VM
    FEBS J; 2010 Jun; 277(12):2567-83. PubMed ID: 20553493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.